Targeted News Service

[Ad Hoc Announcement Pursuant to Art. 53 LR] Roche Provides Update on Phase III PersevERA Study in ER-Positive Advanced Breast Cancer
March 10, 2026

BASEL, Switzerland, March 10 -- Roche, a biotech company, issued the following news release on March 9, 2026:

* * *

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer

* persevERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free survival, but a numerical improvement was observed

* Giredestrant p . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form